Cumulative chemotherapy exposure and social isolation as correlates of caregiver burden and anxiety among family caregivers in outpatient oncology: a cross-sectional study

Cancer is rarely a solitary journey. When a person is diagnosed, the shock and the daily work of treatment ripple outward, pulling family members and friends into a new, demanding role. These individuals, often called informal caregivers, become the unseen backbone of the medical process. They manage complex schedules, drive patients to appointments, monitor side effects, and hold the emotional space for someone facing a life-threatening illness. While the patient is the focus of the doctor's attention, these caregivers often neglect their own well-being, absorbing stress that can lead to deep exhaustion and worry. Medical science has long recognized that supporting the patient means supporting the person who cares for them, yet the specific moments when this support is most needed remain difficult to pinpoint.

A recent study conducted in Turkey sought to map these hidden pressures. Researchers wanted to understand what makes a family caregiver feel overwhelmed or anxious while their loved one is undergoing active chemotherapy. They were particularly interested in whether the length of time since a cancer diagnosis was the main driver of stress, or if the intensity of the treatment itself played a larger role. By looking at hundreds of caregivers in an outpatient clinic, the team aimed to identify the specific factors that predict when a caregiver is struggling, so that hospitals could offer help at the right time.

The study took place at a major cancer center in İzmir, Turkey, between October 2025 and May 2026. Researchers approached adults who were accompanying patients receiving chemotherapy in the waiting areas. To be included, the caregivers had to be at least eighteen years old, able to read Turkish, and have been the primary helper for at least one month. The team excluded anyone with a known history of severe mental illness or cognitive issues to ensure the results reflected the stress of caregiving rather than pre-existing conditions. Out of 634 people invited to participate, 494 completed the survey with all the necessary information. This group represented a wide mix of people: about 56 percent were women, the average age was 46, and most were either spouses or children of the patient. The patients they cared for had various types of cancer, with colon, breast, and lung cancers being the most common.

To measure how these caregivers were feeling, the researchers used two standard tools that had been adapted for Turkish speakers. One tool asked about the burden of caregiving, covering feelings of being trapped, embarrassed, or physically tired. The other measured anxiety, looking at symptoms like nervousness, fear, and physical tension. The results showed that these two feelings often went hand in hand. Caregivers who reported high levels of burden also reported high levels of anxiety, and the two scores were strongly linked. On average, the caregivers in this group showed signs of moderate burden and mild to moderate anxiety, but the range was wide, with some individuals reporting very high levels of distress.

The most striking discovery was what drove this distress. The researchers found that the total amount of time a patient had been receiving chemotherapy was the strongest predictor of how burdened and anxious the caregiver felt. This factor mattered more than how long it had been since the cancer was first diagnosed. A caregiver whose loved one had been in treatment for a year or more was significantly more likely to be struggling than someone whose loved one had only been in treatment for a few months, even if the diagnosis for both had happened years ago. This suggests that the cumulative weight of repeated treatments, hospital visits, and the uncertainty of each new cycle wears people down more than the passage of time alone.

Other factors also played a clear role. Caregivers who felt they had no active social support network—meaning they received no practical help from other family or friends—reported much higher levels of burden. Living with the patient was another significant factor; those who shared a home with the person they cared for were more likely to report higher anxiety. This may be because living together means the caregiver is constantly exposed to the patient's suffering and the demands of the illness, leaving little room for rest. Interestingly, being a woman was linked to higher anxiety levels compared to being a man, while having a university education was linked to higher feelings of burden, perhaps due to the conflict between work responsibilities and caregiving duties.

The study also looked at how often patients were hospitalized for cancer-related emergencies. Caregivers whose patients had been hospitalized frequently reported higher levels of both burden and anxiety. This makes sense, as each hospitalization represents a crisis, a disruption to daily life, and a reminder of the severity of the illness. However, the researchers noted that the type of cancer or the patient's age did not explain the differences in caregiver stress as well as the treatment history and social circumstances did.

It is important to understand the limits of this research. Because the study looked at a single moment in time, it cannot prove that one thing causes another. For example, while the data shows that social isolation is linked to higher burden, it does not prove that isolation causes the burden; it is possible that caregivers who are already overwhelmed withdraw from their social circles. Similarly, the study cannot say for certain that the treatment exposure causes the anxiety, though the strong link suggests it is a major factor. The researchers also noted that they did not capture details about the specific stage of the cancer or the patient's overall health, which might explain some of the stress that remained unaccounted for in their models.

Despite these limitations, the findings offer a clear picture of who is at risk. The profile of a caregiver most likely to be struggling includes someone who is socially isolated, lives with the patient, is female, and is caring for someone who has been undergoing chemotherapy for a long time or has frequent hospital stays. The study suggests that the outpatient chemotherapy waiting room is a critical place to check in on these individuals. Instead of waiting until a patient reaches the very end of life to offer support, medical teams could use the length of treatment and the caregiver's social situation as early warning signs. By identifying those who are carrying the heaviest load, hospitals could connect them with counseling, peer support, or practical help before they reach a breaking point. This approach treats the family unit as a whole, recognizing that the health of the caregiver is just as vital to the cancer journey as the health of the patient.